Cytosolic delivery of bacterial metabolites by riboflavin transporters promotes MR1 antigen presentation and MAIT cell recognition
Immunology & Cell Biology · 2026-07 · 104 (6) · 595-608
DOI: 10.1111/imcb.70130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology & Cell Biology, online erschienen am 06.05.2026. Verfasst von Sebastian Cruz-Gomez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Austr…. Hauptthemen laut MEDLINE: Mucosal-Associated Invariant T Cells, Riboflavin, Antigen Presentation, Histocompatibility Antigens Class I. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, Australian Research Council, National Health and Medical Research Council of Australia.
Abstract (Originalsprache)
Major histocompatibility complex class I‐related protein 1 (MR1) presents microbial Vitamin B‐related metabolite antigens (VitBAg) at the cell surface to activate mucosal‐associated invariant T (MAIT) cells. Precisely how antigen‐presenting cells capture these MR1 ligands is not known. Here, we show that the most effective route for presentation of bacterial VitBAg involves passage through the cytosol. Consistent with structural similarities with riboflavin, we find that VitBAg presentation is inhibited by riboflavin. We further show that riboflavin carriers transport VitBAg into cells and enhance MR1 antigen presentation to MAIT cells. However, elimination of specific riboflavin carriers does not ablate VitBAg presentation, indicating cells possess redundant mechanisms to internalize this family of MR1 ligands. Our findings provide new insights into the intracellular pathway used by VitBAg to bind MR1 molecules and identify potential approaches to boost MR1‐mediated MAIT cell responses for therapeutic benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
- Metabolomics Australia, Bio21 Institute of Molecular Science and Biotechnology, University of Melbourne, Melbourne, VIC, Australia.
- School of Medicine, Tsinghua University, Beijing, China.
- Centre for Chemistry and Drug Discovery, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
- Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, QLD, Australia.
- Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Förderung
- NIH HHS
- Australian Research Council
- National Health and Medical Research Council of Australia
- Cass Foundation
- National Institutes of Health
Zitieren
APA
Cruz-Gomez, S., Lim, H. J., Nijagal, B., Yang, Y., Lau, N., Mak, J. Y., Fairlie, D. P., Newton, H., Salio, M., Villadangos, J. A., & McWilliam, H. E. (2026). Cytosolic delivery of bacterial metabolites by riboflavin transporters promotes MR1 antigen presentation and MAIT cell recognition. Immunology & Cell Biology, 104(6), 595-608. https://doi.org/10.1111/imcb.70130
Vancouver
Cruz-Gomez S, Lim HJ, Nijagal B, Yang Y, Lau N, Mak JY, et al. Cytosolic delivery of bacterial metabolites by riboflavin transporters promotes MR1 antigen presentation and MAIT cell recognition. Immunology & Cell Biology. 2026;104(6):595-608. doi:10.1111/imcb.70130
BibTeX
@article{CruzGomez2026,
author = {Cruz-Gomez, Sebastian and Lim, Hui Jing and Nijagal, Brunda and Yang, Yuting and Lau, Nicole and Mak, Jeffrey Yw and Fairlie, David P and Newton, Hayley and Salio, Mariolina and Villadangos, Jose A and McWilliam, Hamish Eg},
title = {Cytosolic delivery of bacterial metabolites by riboflavin transporters promotes MR1 antigen presentation and MAIT cell recognition},
journal = {Immunology & Cell Biology},
year = {2026},
volume = {104},
number = {6},
pages = {595--608},
doi = {10.1111/imcb.70130}
}
EUVIMED